SCHEMBL836656

SCHEMBL836656

O=C1C=C(Cl)C(O)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9258011 0.72
SCHEMBL9285114 0.72
SCHEMBL4617564 0.70
SCHEMBL17236310 0.70
SCHEMBL363396 0.70
SCHEMBL9482405 0.67
SCHEMBL4384894 0.66 KDM4E (0.36)
SCHEMBL9812598 0.65
SCHEMBL2225565 0.65 CDC25A (0.35)
SCHEMBL9767231 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2867205-B1 NOVEL CHOLECYSTOKININ RECEPTOR LIGANDS PNB VESPER LIFE SCIENCE PVT LTD (IN) 2018-12-19 EP disclosed
CN-106478517-A A kind of synthetic method of 2 methyl 5 chlorine 2H-Pyridazin-3-one 安徽省鸿鑫生物科技有限公司 2017-03-08 CN disclosed
EP-2867205-A1 NOVEL CHOLECYSTOKININ RECEPTOR LIGANDS PNB Vesper Life Science Pvt Limited (IN) 2015-05-06 EP disclosed
US-8921577-B2 Cholecystokinin receptor ligands PNB Vesper Life Sciences Pvt. Ltd. (IN) 2014-12-30 US disclosed
WO-2014006629-A1 NOVEL CHOLECYSTOKININ RECEPTOR LIGANDS PNB VESPER LIFE SCIENCE PVT LIMITED (IN) 2014-01-09 WO disclosed
US-20140005248-A1 NOVEL CHOLECYSTOKININ RECEPTOR LIGANDS PNB VESPER LIFE SCIENCES PVT LTD. (IN) 2014-01-02 US disclosed
US-8143253-B2 Organic compounds NOVARTIS AG (CH) 2012-03-27 US disclosed
US-8143253-B2 Organic compounds NOVARTIS AG (CH) 2012-03-27 US disclosed
US-8143253-B2 Organic compounds NOVARTIS AG (CH) 2012-03-27 US disclosed
EP-2183027-B1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2011-08-31 EP disclosed
EP-2183027-B1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2011-08-31 EP disclosed
US-20100204235-A1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2010-08-12 US disclosed
US-20100204235-A1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2010-08-12 US disclosed
US-20100204235-A1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2010-08-12 US disclosed
EP-2183027-A1 ORGANIC COMPOUNDS Novartis Ag (CH) 2010-05-12 EP disclosed
WO-2009013335-A1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2009-01-29 WO disclosed
WO-2009013335-A1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2009-01-29 WO disclosed
US-20070123718-A1 Novel 4-amino-2(5H)-furanones ASTON UNIVERSITY (GB) 2007-05-31 US disclosed
EP-1628966-A2 4-AMINO-2(5H)-FURANONES USEFUL AS CHOLECYSTOKININ ANTAGONISTS Aston University (GB) 2006-03-01 EP disclosed
WO-2004106315-A2 4-AMINO-2(5H)-FURANONES USEFUL AS CHOLECYSTOKININ ANTAGONISTS ASTON UNIVERSITY (GB) 2004-12-09 WO disclosed